Document is current
Any future updates will be listed below
-
Authors
Park, John J.
Hamad, Sabine Abou
Stewart, Ashleigh
Carlino, Matteo S.
Lim, Su Yin
Rizos, Helen http://orcid.org/0000-0002-2094-9198
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (2012860)
Tour de Cure
- License Information
-
More Information
Article History
Received: 23 August 2023
Revised: 7 February 2024
Accepted: 9 February 2024
First Online: 28 February 2024
Competing interests
: MSC has served on advisory boards for Bristol-Myers Squibb, Merck Sharp and Dohme, Amgen, Novartis, Pierre Fabre, Roche, Sanofi, Merck, Ideaya, Regeneron, Nektar, Eisai, and honoraria from Bristol-Myers Squibb, MSD, Novartis. The authors have no other relevant affiliations or financial involvement with any organisation or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
